Wolverine World Wide (WWW): Callodine Capital Management, LP and James S. Morrow filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of Wolverine’s common stock.
Wolverine World Wide (WWW): Callodine Capital Management, LP and James S. Morrow filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of Wolverine’s common stock. They report 2,701,360 shares, representing 3.32% of the class as the date of event 09/30/2025.
The filing lists shared voting and dispositive power over 2,701,360 shares and no sole voting or dispositive power. The percentage is calculated using 81,254,351 shares outstanding as of July 21, 2025, as referenced from the company’s Form 10‑Q. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Positive
None.
Negative
None.
FAQ
What stake did Callodine report in Wolverine World Wide (WWW)?
They reported 2,701,360 shares, representing 3.32% of Wolverine’s common stock.
What voting and dispositive powers were disclosed?
They reported shared voting power: 2,701,360, shared dispositive power: 2,701,360, and sole power: 0 for both.
What date does the 13G/A relate to for the ownership event?
The date of event is 09/30/2025.
What share count was used to calculate the ownership percentage?
The calculation used 81,254,351 shares outstanding as of July 21, 2025, referenced from the issuer’s Form 10‑Q.
Who are the reporting persons in this filing?
Callodine Capital Management, LP (type: IA) and James S. Morrow (types: IN, HC).
Does the filing indicate an intent to influence control of Wolverine?
No. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.
Callodine Capital Management, LP
James S. Morrow
Shares reported herein for Callodine Capital Management, LP ("Callodine") represent shares held for the benefit of investment advisory clients of Callodine. Shares reported herein for Mr. Morrow represent the above referenced shares reported for Callodine. Mr. Morrow is the managing member of the general partner of Callodine. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
(b)
Address or principal business office or, if none, residence:
Callodine Capital Management, LP
James S. Morrow
c/o Callodine Capital Management, LP
Two International Place, Suite 1830
Boston, MA 02110
(c)
Citizenship:
Callodine Capital Management, LP - Delaware
James S. Morrow - United States
(d)
Title of class of securities:
Common Stock, $1 par value
(e)
CUSIP No.:
978097103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
2,701,360
(b)
Percent of class:
3.32%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
2,701,360
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
2,701,360
The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon a statement in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended on June 28, 2025, as filed with the Securities and Exchange Commission on August 7, 2025, that there were 81,254,351 shares of Common Stock, $1 par value, of the Issuer outstanding as of July 21, 2025.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Callodine Capital Management, LP
Signature:
By: Callodine Capital Management, LLC, Its General Partner, By: James S. Morrow, Managing Member
Name/Title:
/s/ James S. Morrow, Managing Member
Date:
11/14/2025
James S. Morrow
Signature:
/s/ James S. Morrow
Name/Title:
James S. Morrow
Date:
11/14/2025
Exhibit Information
Exhibit 99.1 - Joint Filing Statement, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed on August 14, 2025 by the Reporting Persons with respect to the Issuer.
